NMD Pharma company information, funding & investors | Dealroom.co
Company Presentation
Company Presentation
NMD Pharma
Nmd Pharma A/S, Aarhus N | firma | krak.dk
NMD Pharma company information, funding & investors | Dealroom.co
Management — NMD Pharma
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
Contact — NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Management — NMD Pharma
NMD Pharma
NMD Pharma to advance neuromuscular disorder therapies with €38m Series A round
Management — NMD Pharma
NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Nmd Pharma A/S, Aarhus N | firma | krak.dk
NMD bags €38M to run orphan neuromuscular disease trials | FierceBiotech
Event: Aarhus - Brew Your Own: Meet the founders - Biopeople
Company Presentation
Investors — NMD Pharma
Management — NMD Pharma
Management — NMD Pharma
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
NMD Pharma - Capnova
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co
